Company: MDCXW
Filing Date: 2025-09-19
Form Type: DRS
Source: 0001062993-25-015719
Chunk: 190

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-19
Form: DRS
Chunk 190
---
x Capital, LP, an entity controlled by Dr. Raza Bokhari. Dr. Raza Bokhari may be deemed the beneficial owner of securities held by RBx Capital, LP. Includes 362,500 common shares underlying stock options that are currently exercisable.

(3)Includes 12,500 common shares underlying stock options and 24,000 common shares underlying Public Warrants that are currently exercisable or will become exercisable.

(4)Includes 85,000 common shares underlying stock options that are currently exercisable.

(5)Includes 107,500 common shares underlying stock options and 24,000 common shares underlying Public Warrants that are currently exercisable.

(6)Includes 112,500 common shares underlying stock options that are currently exercisable.

(7)Includes 100,000 common shares underlying stock options that are currently exercisable.

(8)Includes 2,000,000 common shares held of record by 215 Capital Togo PHL Fund I, LP and 6,250 common shares underlying stock options that are currently exercisable. Ajay Raju's address is Two Liberty Place, 50 S. 16th Street, Suite 2710, Philadelphia, PA 19102.

(9)Includes 46,250 common shares underlying stock options that are currently exercisable.

(10)Includes 46,250 common shares underlying stock options that are currently exercisable.

(11)Includes 46,250 common shares underlying stock options that are currently exercisable.

(12)Includes 46,250 common shares underlying stock options that are currently exercisable.

(13)Includes 46,250 common shares underlying stock options that are currently exercisable.

(14)Includes 2,839,330 common shares held by Velocity Fund Partners, LP, an entity controlled by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani's address is 1100 Stonegate Manor, Cheswick, PA 15024.

Based upon a review of the information provided to us by our transfer agent, as of August 31, 2025, there were 191 record holders of our common shares,one holder of record of our Public Warrants, one holder of record of our Regulation A Warrants, one holder of record of our June 2030 Warrants and one holder of record of our Private Warrants. Such numbers do not include beneficial owners holding our securities through nominee names.

<div align='center'>131

CONFIDENTIAL TREATMENT